EUVIMED · CrossrefZeitschrift
JACC: Heart Failure
ISSN 2213-1779 · Elsevier BV
Neueste Artikel
Sleep Apnea in Heart Failure With Mildly Reduced or Preserved Ejection Fraction
Noninvasive Wearable-Based Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptide Levels
Improved Performance of Transthyretin Cardiac Amyloidosis Score by Addition of High-Sensitivity Troponin I
Medium-Chain Triacylglycerol Improves Cardiac Function in Chronic Heart Failure
Delivering Quadruple Therapy for Heart Failure With Reduced Ejection Fraction in a Customizable Polypill
Dietary Medium-Chain Triacylglycerols Preserve Cardiac Function During High-Fat Feeding and Improve Ketolysis Capacity in Mice
Sodium-Glucose Cotransporter 2 Inhibitor Following Left Ventricular Assist Device Implantation
Disparities in Listing With a Durable Left Ventricular Assist Device After 2018 Heart Allocation Policy Change
National Impact of Optimal Implementation of Guideline-Directed Medical Therapy in Heart Failure With Reduced Ejection Fraction
Residual Inflammatory Risk of Heart Failure and Atherosclerotic CVD in Diabetes
HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection Fraction
If Oral Inotropes Are Good Enough for Our Pets, Why Not for Our Patients With Heart Failure?
Identifying High-Risk Patients
From Atherosclerosis to Heart Failure
The Fifth Pillar
Skeletal Muscle Dysfunction in Heart Failure
The Impact of Artificial Intelligence-Enabled Tools on Electronic Health Record-Based Evidence Generation in Heart Failure
Genotype-Phenotype Associations in Pediatric Hypertrophic Cardiomyopathy
Selective Targeting of a Maladaptive Adipokine—But Not of a Traditional Hemodynamic Phenotype—Produces Predicted Left Heart Benefits in Patients With Heart Failure and Preserved Ejection Fraction
Beyond Wall Thickness
An Uneven Canvas for Vulnerable Hearts
Systemic Microvascular Endothelial Dysfunction in Heart Failure with Preserved Ejection Fraction and Type 2 Diabetes
Safety and Efficacy of Omecamtiv Mecarbil by QRS Duration and Cardiac Resynchronization Therapy in GALACTIC-HF
Implications of SGLT2 Inhibitors, GLP-1RAs, and Nonsteroidal MRAs on the Anticipated Burden of Heart Failure
Sex Differences in Health Status in Heart Failure With Preserved Ejection Fraction
Reinitiation of Optimal Guideline-Directed Medical Therapy After Coronary Bypass Grafting in Heart Failure With Reduced Ejection Fraction
Leadless Cardiac Resynchronization Results in Left Ventricular Reverse Remodeling
Effect of Aficamten in Obstructive Hypertrophic Cardiomyopathy With Comorbidities: Obesity, Hypertension, and Diabetes
From Proband to Relative
Rethinking Authorship in Large Multicenter Clinical Trials
EUVIMED